Loading resource…

Academic Department of Endocrinology, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland
Central diabetes insipidus (CDI) is characterized by the inability to concentrate urine due to a deficiency of arginine vasopressin (AVP). The review discusses the diverse etiologies of CDI, including neoplastic, traumatic, or autoimmune causes. It highlights recent advancements in diagnostic techniques, particularly the copeptin assay, which enhances the accuracy of diagnosing hypotonic polyuria. The management strategies for CDI, including pharmacological treatments like dDAVP, are also explored.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology

2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology

METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology

SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology

GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology

ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology

DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology

OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology

ROLE OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN ACHIEVING WEIGHT LOSS AND IMPROVING CARDIOVASCULAR OUTCOMES IN PEOPLE WITH OVERWEIGHT AND OBESITY
Same clinical topic · Endocrinology